Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur significant order book increase in a growing market is a great sign of confidence.
Read our latest reportUrenco is a UK headquartered company, employing more than 100 people in our head office and more than 450 people at our UK site. We are also in the final stages of building a circa £700 million facility in Capenhurst outside of Chester that currently has 1,500 contractors on site and will employee 95 people when operational in 2017.
Urenco is a world class business, owned in equal parts by the UK Government, the Dutch Government and two German utilities, E.ON and RWE. However, we operate as a stand-alone company. We are a living example of excellent European co-operation over the last 40 years. We believe that Britain being part of the European Union is very important to our company. We think of ourselves as a European based business, with the added benefit of a strong presence in the USA, that supplies the world. To have access to the European Union as a member is of significant importance. Our strategic decisions and long-term investment in the business benefit from having the UK, Germany and the Netherlands within the same economic and market framework.
We can only see advantages to Britain being part of the European Union and believe an exit would bring considerable financial and commercial market uncertainty. We have heard no arguments that in any way suggest that Britain outside of the European Union would benefit our business. We want to see Britain vote in favour of remaining in the European Union, for the benefit of our business, employees and shareholders.
Stephen Billingham,
Chairman, Urenco Ltd on behalf of the Urenco Ltd Board.
Urenco continues to close the gap in mean hourly pay between male and female employees, according to our 2024 Gender Pay Gap Report.
Read more Closing the gap: Urenco’s 2024 Gender Pay Gap ReportUrenco continues to close the gap in mean hourly pay between male and female employees, according to our 2024 Gender Pay Gap Report.
Read more Closing the gap: Urenco’s 2024 Gender Pay Gap ReportThe partnership came under the Medical Radionuclide Innovation Programme (MRIP), a £6 million research and development initiative funded by the UK Government.
Read more Urenco Isotopes celebrates successful research and development partnership with King’s College LondonThe partnership came under the Medical Radionuclide Innovation Programme (MRIP), a £6 million research and development initiative funded by the UK Government.
Read more Urenco Isotopes celebrates successful research and development partnership with King’s College LondonAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries